Obstructive sleep apnea syndrome and its association with vitamin D deficiency

Background: Obstructive sleep apnea syndrome (OSAS) is a widespread disorder characterized by recurrent, partial or complete episodes of apnea due to upper airway tract obstruction during sleeping period. Deficiency of vitamin D has roles in development of many diseases. Association between presence...

Full description

Saved in:
Bibliographic Details
Published in:Journal of endocrinological investigation 2013-10, Vol.36 (9), p.681-685
Main Authors: Mete, T., Yalcin, Y., Berker, D., Ciftci, B., Guven, S. F., Topaloglu, O., Yavuz, H. C., Guler, S.
Format: Article
Language:English
Subjects:
Adult
Body Mass Index
Cross-Sectional Studies
Endocrinology
Female
Humans
Male
Medicine
Medicine & Public Health
Metabolic Diseases
Middle Aged
Original Article
Severity of Illness Index
Sleep Apnea, Obstructive - blood
Sleep Apnea, Obstructive - complications
Vitamin D - analogs & derivatives
Vitamin D - blood
Vitamin D Deficiency - complications
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Obstructive sleep apnea syndrome (OSAS) is a widespread disorder characterized by recurrent, partial or complete episodes of apnea due to upper airway tract obstruction during sleeping period. Deficiency of vitamin D has roles in development of many diseases. Association between presence and severity of OSAS and vitamin D has recently gained research interest. Aim: The aim of our study was to investigate the association between serum 25-hydroxy [25 (OH)] vitamin D levels and severity of disease in patients with OSAS. Material and Methods: One hundred and fifty OSAS patients (50 patients with mild, 50 with moderate, 50 with severe OSAS) who were diagnosed by polysomnography (PSG) and 32 non-OSAS controls who were referred to the Health Ministry Ankara Numune Training and Research Hospital, Endocrinology and Metabolism Department, from January 2010 to May 2011 were included in the study. Serum 25(OH)D, PTH, calcium and phosphorus levels were evaluated in all the patients who were recruited to the study. Results: There was no statistically significant difference in serum 25(OH)D levels between OSAS and controls ( p >0.05). However, in subgroup analysis of OSAS, we found that the patients with severe OSAS had significantly lower levels of 25(OH)D as compared with other groups ( p =0.003). Also, the number of patients with serum 25(OH)D deficiency (
ISSN:0391-4097
1720-8386
DOI:10.3275/8923